Sareum Holdings Share Price Down After AGM Update and Pipeline Progress
Sareum Holdings plc share price (AIM: SAR) was down after the clinical-stage biotechnology company specializing in kinase inhibitors for autoimmune diseases and cancer, provided an operational update at its AGM held on 19 December 2024. The company highlighted significant advancements in its lead programmes, SDC-1801 and SDC-1802, alongside progress with its licensed asset, SRA737. SDC-1801: […]
Sareum Holdings Share Price Down After AGM Update and Pipeline Progress Read More »
